Patents by Inventor Michael Gerometta

Michael Gerometta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Composition and Method of Using Same
    Publication number: 20250296979
    Abstract: Provided herein are pharmaceutical compositions comprising an active agent which is a soluble VEGFR-3 trap molecule. Also provided herein are therapeutic methods and uses involving the pharmaceutical compositions, in particular ocular diseases and disorders, and port devices comprising the pharmaceutical compositions.
    Type: Application
    Filed: September 1, 2023
    Publication date: September 25, 2025
    Inventors: Michael GEROMETTA, Angus TESTER, OLga BUCZEK, Ru CAO
  • Ligand Binding Molecules and Uses Thereof
    Publication number: 20240301370
    Abstract: The present invention is directed to ligand binding molecules and uses thereof to modulate angiogenesis and/or lymphangiogenesis.
    Type: Application
    Filed: November 29, 2023
    Publication date: September 12, 2024
    Inventors: Michael Gerometta, Timothy Adams
  • Ligand binding molecules and uses thereof
    Patent number: 11866739
    Abstract: The present invention is directed to ligand binding molecules and uses thereof to modulate angiogenesis and/or lymphangiogenesis.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: January 9, 2024
    Assignee: VEGENICS PTY LIMITED
    Inventors: Michael Gerometta, Timothy Adams
  • LIGAND BINDING MOLECULES AND USES THEREOF
    Publication number: 20200165584
    Abstract: The present invention is directed to ligand binding molecules and uses thereof to modulate angiogenesis and/or lymphangiogenesis.
    Type: Application
    Filed: October 4, 2019
    Publication date: May 28, 2020
    Inventors: Michael Gerometta, Timothy Adams
  • Ligand binding molecules and uses thereof
    Patent number: 10494617
    Abstract: The present invention is directed to polynucleotides that encode VEGFR-3 ligand binding molecules and uses thereof to modulate angiogenesis and/or lymphangiogenesis. A glycosylation sequon of wildtype VEGFR-3 has been modified to eliminate glycosylation in the encoded ligand binding molecules.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: December 3, 2019
    Assignee: VEGENICS PTY LIMITED
    Inventors: Michael Gerometta, Timothy Adams
  • LIGAND BINDING MOLECULES AND USES THEREOF
    Publication number: 20170349886
    Abstract: The present invention is directed to polynucleotides that encode VEGFR-3 ligand binding molecules and uses thereof to modulate angiogenesis and/or lymphangiogenesis. A glycosylation sequon of wildtype VEGFR-3 has been modified to eliminate glycosylation in the encoded ligand binding molecules.
    Type: Application
    Filed: June 30, 2017
    Publication date: December 7, 2017
    Applicant: VEGENICS PTY LIMITED
    Inventors: MICHAEL GEROMETTA, TIMOTHY ADAMS
  • VEGFR-3 ligand binding molecules and uses thereof
    Patent number: 9745558
    Abstract: The present invention is directed to VEGFR-3 ligand binding molecules and uses thereof to modulate angiogenesis and/or lymphangiogenesis. A glycosylation sequon of wildtype VEGFR-3 has been modified to eliminate glycosylation in the ligand binding molecules.
    Type: Grant
    Filed: February 13, 2014
    Date of Patent: August 29, 2017
    Assignee: VEGENICS PTY LIMITED
    Inventors: Michael Gerometta, Timothy Adams
  • LIGAND BINDING MOLECULES AND USES THEREOF
    Publication number: 20160002612
    Abstract: The present invention is directed to ligand binding molecules and uses thereof to modulate angiogenesis and/or lymphangiogenesis.
    Type: Application
    Filed: February 13, 2014
    Publication date: January 7, 2016
    Inventors: Michael Gerometta, Timothy Adams